Asthma and Respiratory Disorders News

The FDA has approved tezepelumab-ekko for self-administration in a prefilled, single-use pen among patients aged 12 years and older with severe asthma, according to a press release from the manufacturer.

Children and adolescents with asthma experienced statistically significant higher hospital readmission rates during grass pollen season compared with the rest of the year, according to a study published in Pediatric Allergy and Immunology.

Healio compiled the most-read news in allergy, asthma and immunology posted in January.

Children with asthma/wheeze demonstrated a strong relationship between age and airway microbiota, with a modest difference observed based on asthma severity, according to study results published in Annals of the American Thoracic Society.

Children with asthma exposed to bushfire smoke demonstrated a clinically important 5% mean decrease in forced vital capacity percent predicted, according to a study published in Pediatric Allergy and Immunology.

People born between January and June in Finland experienced a higher risk for adult-onset asthma than people born later in the year, with a stronger risk among people with atopic asthma, according to a letter published in Asthma.

Smoking heated tobacco products during pregnancy was associated with allergy — specifically asthma, rhinitis and conjunctivitis, and atopic dermatitis — in offspring, according to a study published in Allergy.

The U.S. Environmental Protection Agency has proposed changing National Ambient Air Quality standards for fine particulate matter to improve respiratory health, but this update could be stronger, according to the American Lung Association.

Adults with asthma experienced more nonrespiratory diseases and multimorbidity than adults without asthma, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

Mepolizumab use was associated with fewer exacerbations, reduced oral corticosteroid use and lower costs among patients with asthma on Medicaid, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.